Home › History › Cannabis in 2010s Pop Culture
⚐ Flag an error How this page was made
Also known as: Cannabis mainstreaming 2010s · Weed culture 2010s America

Cannabis in 2010s Pop Culture

How legalization, media, and celebrity branding normalized cannabis in mainstream American culture.

Automated fact-check pass
15 cited sources
Published
Last reviewed
How this page was made
↯ The honest take

The 2010s genuinely normalized cannabis in mainstream media—TV characters smoking became unremarkable, celebrities built whole brands around it. But the decade also locked in marketing folklore (indica/sativa, the myrcene threshold, broad CBD wellness claims) that doesn't hold up to science. Legal weed created the scaffolding for the modern industry, but it didn't fix the racial inequities of prohibition. All three happened in parallel.

Pop culture didn't shift in a vacuum. In November 2012, Colorado's Amendment 64 and Washington's Initiative 502 passed, making them the first U.S. states to legalize cannabis for adult recreational use [1]. By 2019, eleven states plus Washington D.C. had followed [2]. Canada legalized nationally in 2018 under the Cannabis Act [3]. Strong evidence

These legal changes gave producers, advertisers, and celebrities permissible space to discuss cannabis openly—a shift that would have been career-risky five years earlier. The 2013 Cole Memorandum, a Department of Justice document signaling that federal prosecutors would not prioritize state-legal cannabis activity, created regulatory breathing room that the emerging legal cannabis media ecosystem depended on [4]. Strong evidence

Television and film: from stoner archetype to routine character beat

Cannabis had appeared on television before the 2010s—Showtime's Weeds (2005–2012) carried the character-centric drama template into the early decade. The shift in the 2010s was one of visibility and tone. Broad City (Comedy Central, 2014–2019) depicted cannabis use as an incidental part of millennial adult life rather than plot spectacle or punchline. Netflix's Disjointed (2017), created by Chuck Lorre, was an explicit dispensary-focused sitcom, though it lasted only one season.

Documentary broke faster. CNN's Weed specials with Sanjay Gupta, beginning in 2013, are credited as a turning point in mainstream medical-cannabis reporting. Gupta reversed his earlier public opposition and apologized for it on air [5]. Strong evidence The Charlotte Figi story, featured in those specials, drove national attention to CBD for pediatric epilepsy and helped catalyze a wave of state CBD-specific laws [5][6]. Strong evidence

The 2016 Martha & Snoop's Potluck Dinner Party on VH1—a primetime cooking show featuring a Black rapper and white domestic-lifestyle icon joking openly about cannabis—became a cultural marker of how far mainstream acceptance had moved. Anecdote

Music: hip-hop celebrity and the commercial cannabis pivot

Hip-hop had referenced cannabis throughout its history, but the 2010s saw artists build commercial brands around it. Wiz Khalifa's album Rolling Papers (2011) and its enduring single 'Young, Wild & Free' with Snoop Dogg achieved mainstream radio play in ways that made weed-positive hip-hop commercially viable at scale.

Snoop Dogg executed the most visible celebrity-cannabis pivot: he launched the media company Merry Jane in 2015 and the product line Leafs By Snoop in Colorado that same year [7]. Strong evidence Willie Nelson launched Willie's Reserve in 2015 [8], and Melissa Etheridge, Whoopi Goldberg, and others followed with branded ventures. The template—endorse, license, lend an aesthetic—was established by the mid-2010s and replicated across entertainment and professional sports.

Instagram and the rise of 'canna-chic' aesthetics

Instagram, launched in 2010, became the visual infrastructure for a rebranded cannabis aesthetic. Macro photography of frosted cannabis flowers, glassblower close-ups, and minimalist packaging replaced the tie-dye and Bob Marley visual language of earlier decades.

Retailers like MedMen leaned into Apple-Store-meets-Sephora design; a 2018 New York Times profile called MedMen 'the Apple Store of weed,' a phrase the company embraced [9]. Strong evidence This aesthetic coding—upscale, design-forward, racially and gender-coded as white and feminine-friendly—ran parallel to a carceral reality: Black Americans were arrested for cannabis offenses at roughly four times the rate of white Americans nationally despite similar use rates, according to ACLU analysis of FBI data [10]. Strong evidence Visual mainstreaming and unequal enforcement were contemporaneous phenomena throughout the decade.

CBD, wellness marketing, and the myths that hardened

After the 2018 Farm Bill removed hemp from the Controlled Substances Act, CBD products flooded the consumer market—coffees, dog treats, pillowcases, skincare [11]. Marketing claims raced ahead of evidence. The FDA approved Epidiolex (purified CBD) for specific pediatric epilepsy syndromes in June 2018, a real and well-replicated finding [12] Strong evidence. Almost every other consumer CBD claim from the 2010s—anxiety, sleep, pain, inflammation—ranged from preliminary to unsupported at typical retail dosing Weak / limited.

The decade also entrenched several marketing claims that persist despite weak or no scientific support:

These myths spread partly because the industry needed a vocabulary faster than the science could supply one, and dispensary staff, writers, and marketing copywriters filled the gap with plausible-sounding claims that stuck.

Institutional capital and the 'Green Rush' narrative

By 2018–2019, financial press coverage had shifted from novelty pieces to serious market analysis. Constellation Brands' $4 billion investment in Canopy Growth in August 2018 signaled a turning point—a Fortune 500 alcohol company placing a multibillion-dollar bet on a Schedule I substance [14]. Strong evidence Altria followed with a significant Cronos investment that December [15].

The 'Green Rush' framing dominated business journalism in the back half of the decade, though much of that capital proved overvalued: cannabis stocks crashed in 2019 and subsequent years. What the 2010s did establish was that cannabis had become a legitimate sector for institutional money, ending the era when it existed only in black markets or small licensed operations. Strong evidence

What the decade actually changed—and what it didn't

Stripping away the hype, the 2010s made three durable shifts:

  1. Normalized cannabis use in mainstream media to the point that depicting an adult character using cannabis became unremarkable in television and film.
  2. Created the legal and commercial scaffolding—state regulators, laboratory testing requirements, branded retail formats—that the 2020s cannabis industry runs on.
  3. Generated a stable of marketing folklore (indica/sativa effects, myrcene thresholds, broad CBD wellness promises) that has proven harder to dislodge than prohibition itself, despite limited or no scientific support.

What the decade did not do: meaningfully repair the racial inequities embedded in cannabis prohibition; deliver on most popular wellness claims; or produce a stable, profitable cannabis industry. Those remain contested questions for the 2020s and beyond.

For deeper dives on related topics, see Snoop Dogg and Cannabis Culture.

Sources

  1. Government Colorado Secretary of State. Amendment 64: Use and Regulation of Marijuana. 2012 General Election Results.
  2. Reported National Conference of State Legislatures. State Medical Cannabis Laws (historical tracker).
  3. Government Government of Canada. Cannabis Act (S.C. 2018, c. 16). Royal assent June 21, 2018; in force October 17, 2018.
  4. Government Cole, J. M. (2013). Memorandum for All United States Attorneys: Guidance Regarding Marijuana Enforcement. U.S. Department of Justice, August 29, 2013.
  5. Reported Gupta, S. (2013). Why I changed my mind on weed. CNN, August 8, 2013.
  6. Peer-reviewed Maa, E., & Figi, P. (2014). The case for medical marijuana in epilepsy. Epilepsia, 55(6), 783–786.
  7. Reported Wallace, A. (2015). Snoop Dogg launches Leafs By Snoop, his line of marijuana products. The Cannabist / Denver Post, November 19, 2015.
  8. Reported Schroyer, J. (2015). Willie Nelson to launch own line of marijuana products. Marijuana Business Daily, September 30, 2015.
  9. Reported Schwartz, A. (2018). The Apple Store of Weed. The New York Times Magazine, profile of MedMen.
  10. Reported American Civil Liberties Union (2020). A Tale of Two Countries: Racially Targeted Arrests in the Era of Marijuana Reform. Analysis of 2010s FBI Uniform Crime Reporting data.
  11. Government U.S. Congress. Agriculture Improvement Act of 2018 (Farm Bill), P.L. 115-334. Section 10113 removed hemp from the Controlled Substances Act.
  12. Government U.S. Food and Drug Administration (2018). FDA approves first drug comprised of an active ingredient derived from marijuana to treat rare, severe forms of epilepsy. Press release, June 25, 2018.
  13. Peer-reviewed Sawler, J., Stout, J. M., Gardner, K. M., Hudson, D., Vidmar, J., Butler, L., Page, J. E., & Myles, S. (2015). The Genetic Structure of Marijuana and Hemp. PLOS ONE, 10(8), e0133292.
  14. Reported Bray, C. (2018). Constellation Brands Makes $4 Billion Bet on Cannabis Producer Canopy Growth. The New York Times, August 15, 2018.
  15. Reported Maloney, J., & Chaudhuri, S. (2018). Marlboro Maker Altria to Take 45% Stake in Cannabis Company Cronos Group. The Wall Street Journal, December 7, 2018.

How this page was made

Generation history

Oct 30, 2026
Fact-check pass — raised 9 flags
Oct 30, 2026
Revision
May 11, 2026
Fact-check pass — raised 3 flags
May 11, 2026
Initial draft

Drafted with AI assistance and checked by a separate automated fact-check pass. Not every article has been read by a person. See how articles are made.